Literature DB >> 14649374

Recent developments in our understanding of melanocortin system in the regulation of food intake.

Y K Yang1, C M Harmon.   

Abstract

Obesity has become one of the most significant public health problems facing the world today. However, the pathogenesis of obesity is multifactorial and involves the interaction of genetic and environmental factors. There is a pressing need to better understand the biochemical pathways that control energy intake and expenditure. In the last few years, a number of important signalling molecules have been identified that play important roles in obesity. One family of these molecules is the melanocortin system, which consists of several components: (1) melanocortin peptides; (2) the five seven-transmembrane G-protein coupled melanocortin receptors (MCRs); (3) the endogenous MCR antagonists, agouti and agouti-related protein; (4) the endogenous melanocortin mediators, mahogany, and syndecan. This system plays a key role in the central nervous system control of feeding behaviour and energy expenditure. This article will provide an overview of the anatomy, physiology, and molecular biology of the melanocortin system, and recent developments in our understanding of this system in obesity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14649374     DOI: 10.1046/j.1467-789x.2003.00104.x

Source DB:  PubMed          Journal:  Obes Rev        ISSN: 1467-7881            Impact factor:   9.213


  15 in total

1.  Effects of macrocycle size and rigidity on melanocortin receptor-1 and -5 selectivity in cyclic lactam alpha-melanocyte-stimulating hormone analogs.

Authors:  Alexander V Mayorov; So-Yeop Han; Minying Cai; Matthew R Hammer; Dev Trivedi; Victor J Hruby
Journal:  Chem Biol Drug Des       Date:  2006-05       Impact factor: 2.817

2.  Development of cyclic gamma-MSH analogues with selective hMC3R agonist and hMC3R/hMC5R antagonist activities.

Authors:  Alexander V Mayorov; Minying Cai; Kevin B Chandler; Ravil R Petrov; April R Van Scoy; Zerui Yu; Dustin K Tanaka; Dev Trivedi; Victor J Hruby
Journal:  J Med Chem       Date:  2006-03-23       Impact factor: 7.446

Review 3.  Melanotropins as drugs for the treatment of obesity and other feeding disorders: potential and problems.

Authors:  Minying Cai; Joel Nyberg; Victor J Hruby
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

Review 4.  Melanocortin neurons: Multiple routes to regulation of metabolism.

Authors:  Wen-Jie Shen; Ting Yao; Xingxing Kong; Kevin W Williams; Tiemin Liu
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-05-09       Impact factor: 5.187

5.  Cyclic lactam hybrid α-MSH/Agouti-related protein (AGRP) analogues with nanomolar range binding affinities at the human melanocortin receptors.

Authors:  Alexander V Mayorov; Minying Cai; Erin S Palmer; Dustin K Tanaka; James P Cain; Matthew M Dedek; Bahar Tan; Dev Trivedi; Victor J Hruby
Journal:  Bioorg Med Chem Lett       Date:  2011-03-13       Impact factor: 2.823

Review 6.  Structure, function and regulation of the melanocortin receptors.

Authors:  Yingkui Yang
Journal:  Eur J Pharmacol       Date:  2011-01-03       Impact factor: 4.432

7.  Solid-phase peptide head-to-side chain cyclodimerization: discovery of C(2)-symmetric cyclic lactam hybrid α-melanocyte-stimulating hormone (MSH)/agouti-signaling protein (ASIP) analogues with potent activities at the human melanocortin receptors.

Authors:  Alexander V Mayorov; Minying Cai; Erin S Palmer; Zhihua Liu; James P Cain; Josef Vagner; Dev Trivedi; Victor J Hruby
Journal:  Peptides       Date:  2010-08-03       Impact factor: 3.750

8.  Systematic Backbone Conformational Constraints on a Cyclic Melanotropin Ligand Leads to Highly Selective Ligands for Multiple Melanocortin Receptors.

Authors:  Minying Cai; Udaya Kiran Marelli; Jennifer Bao; Johannes G Beck; Florian Opperer; Florian Rechenmacher; Kaitlyn R McLeod; Morgan R Zingsheim; Lucas Doedens; Horst Kessler; Victor J Hruby
Journal:  J Med Chem       Date:  2015-08-11       Impact factor: 7.446

9.  Amygdalar opioids modulate hypothalamic melanocortin-induced anorexia.

Authors:  Tiffany R Beckman; Qiuying Shi; Allen S Levine; Charles J Billington
Journal:  Physiol Behav       Date:  2008-12-24

10.  Contribution of the transmembrane domain 6 of melanocortin-4 receptor to peptide [Pro5, DNal (2')8]-gamma-MSH selectivity.

Authors:  Min Chen; Minying Cai; David McPherson; Victor Hruby; Carroll M Harmon; Yingkui Yang
Journal:  Biochem Pharmacol       Date:  2008-09-30       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.